It is a time of change for the NHS. As a result there is significant impact on the roles of the pharmacist and the pharmacy team which need to evolve to meet new demands in a challenging environment. Pfizer is committed to investing in the future of pharmacy.




The traditional role of dispensing medicines now exists alongside advanced or enhanced services, such as patient consultation through Medicines Use Reviews (MURs), New Medicines Service (NMS) and adherence programmes to help support people using medicines.

Our aim is to be the leading company to support and collaborate with pharmacists. We believe that pharmacists are the experts in medicines optimisation and we are working with them to help them deliver better patient care.

Access Pfizer, home of Pfizer Healthy Partnerships, is a website for pharmacy professionals across the UK, providing convenient access to: 

  • Online training modules to support your Continued Professional Development
  • Easy to order toolkits and materials to support delivery of services to patients
  • Up-to-date Stock and Account Information 


Access Pfizer has three strands:

Enhancing the patient experience

Helping pharmacy to provide a high quality patient experience with training for pharmacists and support materials for patients.

  • Adherence programmes
  • Therapy area and support materials


Supporting professional development

Providing learning resources and skills development training.

  • Acquire the knowledge and skills to grow
  • Therapy training
  • Business skills training
  • Leadership training


Delivering commercial value

Helping pharmacy to realise commercial opportunities by embarking on a number of initiatives to deliver commercial value for pharmacy businesses.

  • Pfizer commercial offering
  • Daily stock information
  • Statements
  • 24/7 access


For further information on Access Pfizer or Pfizer Healthy Partnerships pharmacy professionals can visit Access Pfizer for Professionals, our one-stop resource for Pfizer’s pharmacy customers.

PP-PFE-GBR-4180 / November 2021